| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 987.283 | 483.079 | 754.481 | 996.166 | 1.810.317 | 2.073.240 | 1.757.454 | 1.721.059 | 2.077.590 | 2.873.859 |
| Total Income - EUR | 987.301 | 483.213 | 842.593 | 1.008.557 | 1.902.313 | 2.114.049 | 1.764.532 | 1.726.066 | 2.478.445 | 3.186.349 |
| Total Expenses - EUR | 1.093.198 | 579.710 | 796.588 | 1.154.501 | 1.845.744 | 2.081.922 | 1.726.509 | 1.914.390 | 2.174.089 | 3.126.637 |
| Gross Profit/Loss - EUR | -105.897 | -96.497 | 46.005 | -145.945 | 56.569 | 32.128 | 38.023 | -188.324 | 304.356 | 59.713 |
| Net Profit/Loss - EUR | -105.897 | -96.497 | 46.005 | -145.945 | 56.569 | 32.128 | 38.023 | -188.324 | 277.378 | 47.491 |
| Employees | 8 | 8 | 10 | 17 | 19 | 18 | 22 | 24 | 27 | 31 |
Check the financial reports for the company - C. G. V. Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 27.365 | 32.021 | 91.670 | 76.891 | 71.312 | 65.833 | 124.091 | 115.735 | 308.497 | 371.592 |
| Current Assets | 1.470.710 | 1.310.693 | 1.368.691 | 1.542.336 | 1.758.160 | 2.256.728 | 1.873.090 | 1.745.694 | 1.869.439 | 2.104.164 |
| Inventories | 386.161 | 289.394 | 486.923 | 440.273 | 400.271 | 569.354 | 448.182 | 304.868 | 527.767 | 712.577 |
| Receivables | 1.067.137 | 972.961 | 848.264 | 978.282 | 1.270.496 | 1.580.630 | 1.311.572 | 1.372.103 | 1.330.273 | 1.371.267 |
| Cash | 17.412 | 48.338 | 33.504 | 123.782 | 87.393 | 106.744 | 113.336 | 68.723 | 11.400 | 20.320 |
| Shareholders Funds | -112.509 | -207.985 | -148.705 | -291.710 | -229.492 | -193.014 | -149.127 | -290.306 | -42.373 | -52.944 |
| Social Capital | 45 | 45 | 9.890 | 9.709 | 9.521 | 9.340 | 9.133 | 9.162 | 9.134 | 9.083 |
| Debts | 1.610.584 | 1.550.698 | 1.609.067 | 1.910.936 | 2.058.963 | 2.515.574 | 2.146.309 | 2.151.735 | 2.244.835 | 2.528.701 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - C. G. V. Pharma Srl